about
Prostate specific membrane antigen mRNA in blood as a potential predictor of biochemical recurrence after radical prostatectomy.Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis.Prostate volume has prognostic value only in pathologic T2 radical prostatectomy specimens.P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation.Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.Single institutional experience of bladder-preserving trimodality treatment for muscle-invasive bladder cancer.Docetaxel chemotherapy of Korean patients with hormone- refractory prostate cancer:comparative analysis between 1st-line and 2nd-line docetaxel.Analysis of changes in the total lymphocyte and eosinophil count during immunotherapy for metastatic renal cell carcinoma: correlation with response and survivalGenetic variations of α -methylacyl-CoA racemase are associated with sporadic prostate cancer risk in ethnically homogenous Koreans.Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review.Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea.Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy.Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.Validation of the MSKCC and Heng risk criteria models for predicting survival in patients with metastatic renal cell carcinoma treated with sunitinib.Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study.Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis.The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.Gastrointestinal stromal tumor in ileal neobladder.Overestimation of nuclear matrix protein 22 in concentrated urine.A prospective evaluation of conventional cystography for detection of urine leakage at the vesicourethral anastomosis site after radical prostatectomy based on computed tomography.Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high-risk prostate cancer.Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.Clinical value of PTEN in patients with superficial bladder cancer.Incidental prostate cancer detected by cystoprostatectomy in Korean men.Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.Adjuvant intravesical instillation for primary T1G3 bladder cancer: BCG versus MMC in KoreaA Surgically Treated Case of Ureterovesical Amyloidosis of the Bladder in a Patient with Idiopathic ThrombocytopeniaImmune checkpoint inhibitors for urothelial carcinomaEffect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score MatchingCorrelation Analyses of Computed Tomography and Magnetic Resonance Imaging for Calculation of Prostate Volume in Colorectal Cancer Patients with Voiding Problems Who Cannot Have Transrectal UltrasonographySingle-Center Analysis of Human Papillomavirus Infection and P16INK4A Expression among Korean Patients with Penile CancerXanthogranulomatous cystitis associated with suture materialIdentification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumorsReverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancerThe efficacy of transureteroureterostomy for ureteral reconstruction during surgery for a non-urologic pelvic malignancyHaplotype analysis of prostate stem cell antigen and association with prostate cancer riskRenal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract
P50
Q34073699-7BA674BA-4578-4BF7-98E2-BEC3357651A3Q34193061-F82A8693-1C4A-4F27-A6F5-526385A020D4Q35009882-F2440540-2091-4369-A8F4-36F6BF8B478AQ35089340-5DD36B41-25F1-4DEF-BCF4-80152366565FQ35133570-492F8208-8B9E-4E55-BE1B-1D03D265CB5CQ35905142-A05BB43A-78E1-4A74-B7C7-901BBC594A69Q36854105-827029BC-DEC5-4758-826A-FC9A0EB4059EQ37041168-3E0178E2-276E-43B2-A6D9-06C94D52FCA3Q37222476-D0AB73EF-63BD-49B5-A06E-E802D11C9F9DQ37409113-EA72777F-0584-441D-89BB-B836216875B4Q37570284-C6364895-BD94-4F5B-BDE6-A204DD133515Q37660290-5031BD20-97CE-4713-9977-2F9D429291FFQ40200357-D7016655-1EFD-4006-A515-4B034DCE6AAAQ43131963-616AA3A6-B1D5-4849-886C-4DD8095D98B3Q44750072-2AECFFD8-400D-4BFF-93CD-01AA010F9351Q45082802-C30F8D4F-131D-4992-8F4E-DBC3772DFACFQ47110040-F98551E3-3313-428D-B57C-0DFA37BD00AAQ47415923-2627148D-D502-4608-BA93-411A36BAC2CBQ50217752-EC300DAB-DB3D-468C-ACD7-19810DF69259Q50914033-C4C9A547-A5FA-4CB9-94D5-CFE63E43FB65Q51109248-B29EF991-2664-4EAF-BE7C-BE50A8127EA9Q51334130-C140BF99-F602-4AAA-8155-AD5A031D7A30Q53246318-DEAC2128-C3B8-40A3-BD86-BC0CC810F5CCQ53485353-922CB513-2BF6-45C2-8FDC-6E68A877EFF0Q53493936-27DFEF2D-882A-43E0-BA4B-8D0BFC20F617Q53540396-AFEC3808-3DFD-4839-8BD9-0F3678E787F0Q53543091-7DB9C963-C4EF-486D-9A8A-42B0719F138BQ53554361-DCC358CE-90D3-4985-9707-E56E03D5FE73Q57225461-7FAB02EA-DF48-42E5-A5FA-AA03451827A7Q58761180-19E4F78F-C926-4DA0-9039-D58E2277DF23Q58781747-9B9A52C0-A014-425C-B1AD-8F42028E65E2Q60912193-EDBD78C8-D7AE-4259-9548-22041E912181Q64098618-4957D555-2999-4091-82E4-E0479BEE491BQ64116750-20C085A9-CE33-4817-905B-76C52F598141Q74216342-08EE5F63-BCCA-4B79-A092-19A36B4A4727Q79641525-621A8249-F579-4667-84D4-743E5B7A1CB2Q80654302-5F179973-A890-4275-AC0F-40027F4F542BQ81288594-8116DA61-FC9C-41A0-9693-26BAF5AFC43FQ83879386-B4EE52E9-08C9-449C-AD3B-BB1868F3DBC7Q84372924-DEB46154-85D3-4002-852A-49EF6F43C86B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ho Kyung Seo
@ast
Ho Kyung Seo
@en
Ho Kyung Seo
@es
Ho Kyung Seo
@nl
Ho Kyung Seo
@sl
type
label
Ho Kyung Seo
@ast
Ho Kyung Seo
@en
Ho Kyung Seo
@es
Ho Kyung Seo
@nl
Ho Kyung Seo
@sl
prefLabel
Ho Kyung Seo
@ast
Ho Kyung Seo
@en
Ho Kyung Seo
@es
Ho Kyung Seo
@nl
Ho Kyung Seo
@sl
P108
P106
P31
P496
0000-0003-2601-1093